https://advesya.com/cctx-001-a-first-in-class-autologous-anti-il-1rap-car-t-celltherapy-for-the-treatment-of-relapsed-refractory-aml/ 2024-07-25T10:06:22+00:00 https://advesya.com/wp-content/uploads/2024/07/EHA-e1721901912241.jpg https://advesya.com/wp-content/uploads/2024/07/Screenshot-2024-07-11-at-15.14.55.png https://advesya.com/abstract-2360-adv101-a-first-in-class-il-1rap-adc-demonstrates-significant-anti-tumor-activity-in-solid-tumor-models/ 2024-07-25T10:06:45+00:00 https://advesya.com/wp-content/uploads/2024/06/keyvisual_poster_news_02.jpg https://advesya.com/wp-content/uploads/2024/06/keyvisual_poster_news_02.jpg https://advesya.com/wp-content/uploads/2024/07/Screenshot-2024-07-10-at-18.11.47.png https://advesya.com/abstract-6322-cctx-001-car-t-cells-targeting-the-aml-specific-antigen-il-1rap-show-robust-pre-clinical-anti-tumor-efficacy/ 2024-07-25T10:06:57+00:00 https://advesya.com/wp-content/uploads/2024/06/keyvisual_poster_news_02.jpg https://advesya.com/wp-content/uploads/2024/06/keyvisual_poster_news_02.jpg https://advesya.com/wp-content/uploads/2024/07/Screenshot-2024-07-10-at-18.25.37.png https://advesya.com/ksenija-pavletics-interview-on-bfm-business-france-2/ 2024-07-25T10:38:36+00:00 https://advesya.com/wp-content/uploads/2024/06/bg-video-ksenjia.jpg https://advesya.com/advesya-granted-ema-clinical-trial-application-cta-for-cctx-001/ 2024-07-30T08:12:08+00:00 https://advesya.com/wp-content/uploads/2024/07/DALL%C2%B7E-2024-07-25-10.43.19-A-professional-and-clean-drawing-for-a-press-release-announcing-the-approval-of-a-clinical-trial-application-by-the-European-Medicines-Agency-EMA.-T-e1721901096951.webp https://advesya.com/adv-101-preclinical-efficacy-in-esophageal-cancer-presented-at-camsoc2014/ 2024-11-07T11:00:01+00:00 https://advesya.com/wp-content/uploads/2024/08/Screenshot-2024-11-01-at-16.34.57.png https://advesya.com/wp-content/uploads/2024/08/Screenshot-2024-11-01-at-16.50.38-e1730480141193.png https://advesya.com/ash24/ 2024-12-09T15:46:42+00:00 https://advesya.com/wp-content/uploads/2024/11/ASH2023_SM_0139_resized.jpg